The Cell Therapy Manufacturing Center (CTMC) in Houston, TX is a pioneering organization that combines cutting-edge biopharmaceutical manufacturing technology with the expertise of MD Anderson Cancer Center to accelerate the impact of cell therapy on cancer patients. With a commercialization mindset and a focus on innovative research, CTMC operates at the intersection of industrial manufacturing and data-rich clinical trials, aiming to rapidly develop and robustly deliver novel scientific breakthroughs into effective cancer medicines.
With a team of industry veterans and former academic scientists, CTMC brings scientific depth to the development of cell therapy processes and platforms. By maintaining close relationships with Resilience's manufacturing technology development engineers and MD Anderson's key opinion leaders, CTMC takes a rigorous approach to process and analytical development, ensuring the highest quality standards. Through its integrated approach, CTMC coordinates all aspects of cell therapy manufacturing, patient care, and clinical analysis, providing novel therapies with the best chance to demonstrate their potential and prove their efficacy in a patient-efficient manner.
Generated from the website